Longeveron
company
About
Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3.80M
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases. This is through the testing of allogeneic human Mesenchymal Stem Cells (MSCs) that are derived from the bone marrow of young, healthy donors. The Longeveron-grown Mesenchymal Stem Cell (LMSCs) product is manufactured in Longeveron’s cell processing facility located in Miami, Florida.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$4.55M
Longeveron has raised a total of
$4.55M
in funding over 2 rounds. Their latest funding was raised on
Oct 18, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 18, 2018 | Grant | $3.80M | 1 |
National Institutes of Health
|
— | Detail |
| May 22, 2018 | Grant | $750K | 1 |
TEDCO
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Longeveron is funded by 2 investors.
National Institutes of Health
and TEDCO
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
TEDCO
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
